FDA — authorised 13 December 1990
- Marketing authorisation holder: ACTAVIS LABS UT INC
- Status: approved
🇺🇸 Condylox in United States
FDA authorised Condylox on 13 December 1990
Marketing authorisations
FDA — authorised 13 December 1990
- Application: NDA019795
- Marketing authorisation holder: TEVA BRANDED PHARM
- Local brand name: CONDYLOX
- Indication: SOLUTION — TOPICAL
- Status: approved
FDA — authorised 13 March 1997
- Application: NDA020529
- Marketing authorisation holder: ALLERGAN
- Local brand name: CONDYLOX
- Indication: GEL — TOPICAL
- Status: approved
Condylox in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Condylox approved in United States?
Yes. FDA authorised it on 13 December 1990; FDA authorised it on 13 December 1990; FDA authorised it on 13 March 1997.
Who is the marketing authorisation holder for Condylox in United States?
ACTAVIS LABS UT INC holds the US marketing authorisation.